Published in CMAJ on May 04, 1999
2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary]. CMAJ (2007) 9.10
Lifestyle approaches to managing high blood pressure. New Canadian guidelines. Can Fam Physician (1999) 0.98
Canadian Hypertension Education Program: the evolution of hypertension management guidelines in Canada. Can J Cardiol (2008) 0.87
Effects of a DASH-like diet containing lean beef on vascular health. J Hum Hypertens (2014) 0.86
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension. CMAJ (1999) 0.82
Markers of loss of control of hypertension. Can Fam Physician (2003) 0.81
Expanding role of a blood center. Asian J Transfus Sci (2012) 0.75
Body weight and mortality among women. N Engl J Med (1995) 11.04
Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med (1997) 9.36
Report of the Canadian Hypertension Society Consensus Conference: 1. Introduction. CMAJ (1993) 6.20
Effect of weight loss without salt restriction on the reduction of blood pressure in overweight hypertensive patients. N Engl J Med (1978) 3.64
Body weight, weight change, and risk for hypertension in women. Ann Intern Med (1998) 3.56
Weight and blood pressure. Findings in hypertension screening of 1 million Americans. JAMA (1978) 2.54
Weight loss intervention in phase 1 of the Trials of Hypertension Prevention. The TOHP Collaborative Research Group. Arch Intern Med (1993) 2.26
Hazards of obesity--the Framingham experience. Acta Med Scand Suppl (1988) 1.81
Weight reduction in a blood pressure clinic. Br Med J (1978) 1.67
Pharmacologic and nutritional treatment of mild hypertension: changes in cardiovascular risk status. Ann Intern Med (1990) 1.46
Effect of dexfenfluramine treatment on body weight, blood pressure and noradrenergic activity in obese hypertensive patients. Eur J Clin Pharmacol (1992) 1.45
Comparison of weight reduction with metoprolol in treatment of hypertension in young overweight patients. Lancet (1985) 1.30
Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity. Hypertension (1994) 1.23
Lifestyle intervention: results of the Treatment of Mild Hypertension Study (TOMHS). Prev Med (1995) 1.20
Failure of weight reduction to reduce mildly elevated blood pressure: a randomized trial. J Hypertens (1984) 1.07
Obesity and its relation to cardiovascular disease risk factors in Canadian adults. Canadian Heart Health Surveys Research Group. CMAJ (1992) 1.05
The Trial of Antihypertensive Interventions and Management (TAIM) study. Adequate weight loss, alone and combined with drug therapy in the treatment of mild hypertension. Arch Intern Med (1992) 1.04
Weight reduction versus antihypertensive drug therapy in obese men with high blood pressure: effects upon plasma insulin levels and association with changes in blood pressure and serum lipids. J Hypertens (1992) 0.80
Construct design for efficient, effective and high-throughput gene silencing in plants. Plant J (2001) 7.73
Rational intravenous doses of theophylline. N Engl J Med (1973) 7.44
Awareness, treatment, and control of hypertension in Canada. Am J Hypertens (1997) 4.76
Adverse reactions during hospitalization. Can Med Assoc J (1967) 3.96
Clinical pharmacokinetics of theophylline. Clin Pharmacokinet (1978) 3.86
Dosage of theophylline in bronchial asthma. N Engl J Med (1975) 3.04
Adverse drug reactions during hospitalization. Can Med Assoc J (1967) 2.01
An educational program in digitalis therapy. JAMA (1972) 1.99
A novel process for updating recommendations for managing hypertension: rationale and methods. Can J Cardiol (2000) 1.71
A novel technique for measuring bladder wall thickness in women using transvaginal ultrasound. Ultrasound Obstet Gynecol (1994) 1.69
Theophylline kinetics in acute pulmonary edema. Clin Pharmacol Ther (1977) 1.50
Canadian Cardiovascular Society Consensus Conference 2002: Management of heart disease in the elderly patient. Can J Cardiol (2004) 1.44
Fish consumption and cardiovascular mortality in Canada: an inter-regional comparison. Am J Prev Med (1988) 1.44
The management of hypertension in Canada: a review of current guidelines, their shortcomings and implications for the future. CMAJ (2001) 1.44
Clinical assessment of blood pressure. J Hum Hypertens (1990) 1.41
Theophylline disposition in patients with hepatic cirrhosis. N Engl J Med (1977) 1.41
Predictors of cigarette and alcohol susceptibility and use among Hispanic migrant adolescents. Prev Med (2000) 1.32
Pharmacokinetics of intravenous theophylline. Clin Pharmacol Ther (1973) 1.30
Surveillance for stroke in Canada. Health Rep (1994) 1.30
Clinical and chemical interactions between iron preparations and ciprofloxacin. Br J Clin Pharmacol (1991) 1.24
Evaluation of a tobacco and alcohol use prevention program for Hispanic migrant adolescents: promoting the protective factor of parent-child communication. Prev Med (2000) 1.23
Nutrition communication for a Latino community: formative research foundations. Fam Community Health (2001) 1.19
Accurate blood pressure measurement: why does it matter? CMAJ (1999) 1.17
Self-measurement of blood pressure: benefits, risks and interpretation of readings. The Canadian Coalition for High Blood Pressure Prevention and Control. Can J Cardiol (1995) 1.17
Human liver phenol sulfotransferase: assay conditions, biochemical properties and partial purification of isozymes of the thermostable form. Biochem Pharmacol (1987) 1.16
Anti-arrhythmic effects of prazosin and propranolol during coronary artery occlusion and re-perfusion in dogs and pigs. Br J Pharmacol (1984) 1.15
Pharmacokinetic analysis of the disposition of intravenous theophylline in young children. J Pediatr (1976) 1.15
Lack of control of high blood pressure and treatment recommendations in Canada. Can J Cardiol (2002) 1.15
Adherence to pharmacologic management of hypertension. Can J Public Health (1999) 1.12
Genetic diversity of Toxoplasma gondii isolates from chickens from Brazil. Vet Parasitol (2008) 1.12
Antihypertensive and biochemical effects of chlorthalidone. Clin Pharmacol Ther (1977) 1.11
The impact of hydration changes in fresh bio-tissue on THz spectroscopic measurements. Phys Med Biol (2008) 1.10
A complex arrangement of genes at a starch branching enzyme I locus in the D-genome donor of wheat. Genome (1997) 1.10
Prescription of nonsteroidal anti-inflammatory drugs for elderly people in Alberta. CMAJ (1994) 1.09
Time-dependent fluorescence depolarization and lifetime studies of myosin subfragment-one in the presence of nucleotide and actin. J Supramol Struct (1975) 1.09
Amantadine kinetics in healthy young subjects after long-term dosing. Clin Pharmacol Ther (1979) 1.08
Influencing prescribing patterns. Can Fam Physician (1998) 1.07
Treatment of benign prostatic hypertrophy with medrogestone. Clin Pharmacol Ther (1971) 1.06
Structure of myosin subfragment 1 from low-angle X-ray scattering. Biochemistry (1980) 1.06
Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics. Clin Pharmacol Ther (1972) 1.04
Antagonism of spironolactone-induced natriuresis by aspirin in man. N Engl J Med (1973) 1.03
Location and gross morphology of the nasopalatine duct in human adults. Arch Otolaryngol Head Neck Surg (2000) 1.02
Cardiovascular response to increasing theophylline concentrations. Eur J Clin Pharmacol (1977) 1.01
A technique to measure the ability of the human nose to warm and humidify air. J Appl Physiol (1985) (1999) 1.01
Correlation of disopyramide pharmacokinetics with efficacy in ventricular tachyarrhythmia. J Int Med Res (1976) 1.01
Approach to drug therapy for hypertension. Can Med Assoc J (1979) 1.01
Folate status, vascular disease and cognition in elderly Canadians. Age Ageing (1998) 1.00
Guidelines for measurement of blood pressure, follow-up, and lifestyle counselling. Canadian Coalition for High Blood Pressure Prevention and Control. Can J Public Health (1995) 1.00
Interaction of isoxicam with acetylsalicylic acid. Br J Clin Pharmacol (1984) 0.98
Changes in the patterns of blood pressure treatment in North America from 1960-1990. J Hum Hypertens (1993) 0.95
Effect of phenobarbital on the disposition of intravenous theophylline. Clin Pharmacol Ther (1977) 0.94
Comparison of the efficacy and safety of once-daily versus twice-daily formulations of diltiazem in the treatment of systemic hypertension. The Canadian Multicenter Diltiazem-CD Hypertension Trial Group. Cardiovasc Drugs Ther (1995) 0.93
Nifedipine and mortality risk in the elderly: relevance of drug formulation, dose and duration. Pharmacoepidemiol Drug Saf (2000) 0.93
Intrinsic segmental flexibility of the S-1 moiety of myosin using single-headed myosin. Biochemistry (1978) 0.92
The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure. Can J Cardiol (2001) 0.92
Antihypertensive responses to spironolactone in normal renin hypertension. Clin Pharmacol Ther (1978) 0.92
Drainage of subretinal fluid with the argon laser. Am J Ophthalmol (1993) 0.91
Transfusion-induced specific anti-factor XI inhibitor in a patient with previously unrecognized factor XI deficiency. Am J Clin Pathol (1988) 0.91
The effect of crossing legs on blood pressure: a randomized single-blind cross-over study. Blood Press Monit (1999) 0.90
Self-measurement of blood pressure: recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control. Can J Cardiol (1995) 0.89
Massive aortic aneurysm presenting as chest wall swelling. Heart (2004) 0.89
Cognitive and emotional functioning in hypopituitary short-statured children. Schizophr Bull (1982) 0.88
Weight-loss-associated changes in bone mineral density and bone turnover after partial weight regain with or without aerobic exercise in obese women. Eur J Clin Nutr (2011) 0.88
Correlation of peripheral white cell and bone marrow changes with folate levels in pregnancy and their clinical significance. J Clin Pathol (1966) 0.88
The two-compartment open-system kinetic model: a review of its clinical implications and applications. J Pediatr (1976) 0.88
Project Salsa: development and institutionalization of a nutritional health promotion project in a Latino community. Am J Health Promot (1998) 0.88
Father involvement in infant care: two longitudinal studies. Int J Nurs Stud (1993) 0.87
Duration of cardiac effects of timolol and propranolol. Clin Pharmacol Ther (1976) 0.87
The effect of ferrous sulfate and pH on L-dopa absorption. Can J Physiol Pharmacol (1990) 0.87
A Canadian multicentre study of a 48 h infusion of milrinone in patients with severe heart failure. Can J Cardiol (1991) 0.86
Treatment of HBsAg-positive chronic active hepatitis with human fibroblast interferon. Gut (1978) 0.86
Comparative effects of vasodilator drugs on flow distribution and venous return. Can J Physiol Pharmacol (1985) 0.86
Effects of large and small doses of hydrochlorothiazide in hypertensive patients. Clin Pharmacol Ther (1970) 0.85
Accurate, reproducible measurement of blood pressure. CMAJ (1990) 0.85
Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema. Br J Clin Pharmacol (1980) 0.85
Science, Imagination, and Art. Science (1957) 0.85
Improved method for estimating chlorthalidone in body fluids. J Pharm Sci (1974) 0.85
From death and disability to patient empowerment: an interprofessional partnership to achieve cardiovascular health in Canada. Can J Public Health (2002) 0.85
Antiarrhythmic drugs: electrophysiological and pharmacokinetic considerations. Annu Rev Pharmacol (1975) 0.84
Cardiovascular effects of enprofylline and theophylline. Clin Pharmacol Ther (1986) 0.84
Smoking and theophylline dose schedules. Ann Intern Med (1978) 0.83
Hemodynamic effects of ethacrynic acid in anephric dogs. J Pharmacol Exp Ther (1971) 0.83
T-ray Imaging and Tomography. J Biol Phys (2003) 0.83
Pharmacokinetic and pharmacodynamic interactions between nisoldipine and propranolol. Clin Pharmacol Ther (1988) 0.83
Surgery for severe constipation: the use of radioisotope transit scan and barium evacuation proctography in patient selection. Aust N Z J Surg (1994) 0.83
Biotransformation of furosemide in patients with acute pulmonary edema. Drug Metab Dispos (1980) 0.83
Epidural anesthesia in pregnant patients with low platelet counts. Obstet Gynecol (1988) 0.83
Cardiac and vascular effects of atrial natriuretic factor and sodium nitroprusside in healthy men. Circulation (1989) 0.82
Biologic activity of metronidazole in plasma and urine of volunteers with normal or impaired renal function. Surgery (1983) 0.82
Metronidazole kinetics in dialysis patients. Surgery (1983) 0.82
Platelet phenol sulfotransferase and erythrocyte catechol-O-methyltransferase activities: correlation with methyldopa metabolism. Clin Pharmacol Ther (1984) 0.82
Assessment of blood pressure measuring techniques. Med Educ (1992) 0.82
Achieving cardiovascular health through continuing interprofessional development. Can J Public Health (2002) 0.82
Clinical problem solving based on the 1999 Canadian recommendations for the management of hypertension. CMAJ (1999) 0.82
Listen to me, too! Lessons from involving children with complex healthcare needs in research about multi-agency services. Child Care Health Dev (2007) 0.82